In Nigeria, specifically, Goldstein Research predicts a robust Compound Annual Growth Rate (CAGR) of 9.1% for the pharmaceutical market from 2017 to 2030. This aligns with McKinsey Company’s 2017 analysis, which projected an annual market growth of up to 9%, potentially reaching $3.6 billion